All Stories

  1. Clear the Fog around Parathyroid Hormone Assays

    Article • Clinical Journal of the American Society of Nephrology, March 2018, American Society of Nephrology

    Prof. Dr. Berthold Hocher

  2. Need for better PTH assays for clinical research and patient treatment

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2017, De Gruyter

    Prof. Dr. Berthold Hocher

  3. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy

    Article • Journal of Molecular Endocrinology, April 2017, Bioscientifica

    Prof. Dr. Berthold Hocher

  4. Endothelin and Tubulointerstitial Renal Disease

    Article • Seminars in Nephrology, March 2015, Elsevier

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher, Professor Albert Ong

  5. Fetal Programming – gesundes Altern beginnt im Mutterleib

    Article • Zeitschrift für Orthomolekulare Medizin, June 2014, Thieme Publishing Group

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  6. Endothelin receptor antagonists in clinical research — Lessons learned

    Article • Life Sciences, December 2013, Elsevier

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  7. Nonoxidized, Biologically Active Parathyroid Hormone Determines Mortality in Hemodialysis Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2013, Endocrine Society

    Prof. Dr. Berthold Hocher, Dr. Alexandra Scholze

  8. Linagliptin as add-on therapy to insulin for patients with type 2 diabetes

    Article • Vascular Health and Risk Management, November 2013, Taylor & Francis

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  9. Animal Models of the Endothelin System

    Article • January 2009, Springer Science + Business Media

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  10. Letter to the Editor

    Article • American Heart Journal, January 2006, Elsevier

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  11. Reply

    Article • Journal of Hypertension, September 2004, Wolters Kluwer Health

    Prof. Dr. Berthold Hocher

  12. Relaxin Is an Independent Risk Factor Predicting Death in Male Patients With End-Stage Kidney Disease

    Article • Circulation, April 2004, Wolters Kluwer Health

    Prof. Dr. Berthold Hocher

  13. ETB receptor deficiency causes salt-sensitive hypertension

    Article • Journal of Molecular Medicine, December 2002, Springer Science + Business Media

    Prof. Dr. Berthold Hocher, Professor Berthold Hocher

  14. The advanced fetal programming hypothesis

    Article • Nephrology Dialysis Transplantation, June 2001, Oxford University Press (OUP)

    Prof. Dr. Berthold Hocher

  15. Endothelins and Cardiac Fibrosis   Response

    Article • Hypertension, November 1999, Wolters Kluwer Health

    Prof. Dr. Berthold Hocher

  16. Influence of Dopaminergic Agonists/Antagonists on Fucose Metabolism in the Rat Brain

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1993, De Gruyter

    Prof. Dr. Berthold Hocher